Imetelstat Side Effects
Medically reviewed by Drugs.com. Last updated on Aug 10, 2024.
Applies to imetelstat: parenteral lyophilized powder.
Side effects include:
Most common adverse reactions (≥10%): decreased platelets, decreased white blood cells, decreased neutrophils, increased AST, increased alkaline phosphatase, increased ALT, fatigue, prolonged partial thromboplastin time, arthralgia/myalgia, COVID-19 infections, headache.
For healthcare professionals
Applies to imetelstat: intravenous powder for injection.
General adverse events
Most common adverse reactions occurring in at least 10% of patients included laboratory abnormalities are decreased platelets, decreased white blood cells, decreased neutrophils, increased AST, increased alkaline phosphatase, increased ALT, fatigue, prolonged partial thromboplastin time, arthralgia/myalgia, coronavirus disease 2019 (COVID-19) infections, and headache.[Ref]
Cardiovascular
- Common (1% to 10%): Atrial fibrillation/flutter
- Frequency not reported: Hypertension
Dermatologic
- Common (1% to 10%): Pruritus
Gastrointestinal
- Frequency not reported: Gastrointestinal hemorrhage
Hematologic
- Very common (10% or more): Decreased platelet count (97%), decreased white blood cell count (94%), decreased neutrophil count (92%), prolonged partial thromboplastin time (26%)
- Common (1% to 10%): Hematoma
- Frequency not reported: Febrile neutropenia
Hepatic
- Very common (10% or more): Increased AST (53%), increased ALT (43%)
Immunologic
- Common (1% to 10%): Infusion-related reactions
Infusion-related reactions included abdominal pain, arthralgia, asthenia, back pain, bone pain, diarrhea, erythema, headache, hypertensive crisis, malaise, non-cardiac chest pain, pruritus, and urticaria.
Metabolic
- Very common (10% or more): Increased alkaline phosphatase (48%)
Musculoskeletal
- Very common (10% or more): Arthralgia/myalgia (25%)
- Common (1% to 10%): Fractures (femur, hand, hip, humerus, lumbar, thoracic)
Nervous system
- Very common (10% or more): Headache (13%)
- Common (1% to 10%): Syncope
Other
- Very common (10% or more): Fatigue/asthenia/malaise (29%), COVID-19 infections (19%)
- Frequency not reported: Sepsis
Renal
- Common (1% to 10%): Urinary tract infection/renal abscess/cystitis
See also:
References
1. (2024) "Product Information. Rytelo (imetelstat)." Geron Corporation
More about imetelstat
- Check interactions
- Compare alternatives
- Dosage information
- During pregnancy
- Drug class: miscellaneous antineoplastics
- En español
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Imetelstat side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.
